# SUMATRIPTAN SUCCINATE
> **ANDA213998** · Abbreviated New Drug Application (Generic) · Sponsor: CAPLIN · Approved 2021-07-13
## Drug
- **FDA Application Number:** ANDA213998
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUMATRIPTAN SUCCINATE
- **Generic name:** SUMATRIPTAN
- **Active ingredients:** SUMATRIPTAN SUCCINATE
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** CAPLIN
- **Manufacturer:** Somerset Therapeutics, LLC
- **First approval:** 2021-07-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213998)
---
*MORVS · CC0 1.0*